News & Events
Admera Health and Twist Bioscience Collaborate to Expand Next-Generation Sequencing Service Offerings Through Certified Partnership Program
Admera Health and Twist Bioscience collaborate to expand Next-Generation-Sequencing service offerings as a certified provider through the NGS Prolab program.
Parse Biosciences Welcomes Admera Health as Newest Member of Certified Service Provider Network
Admera Health achieves Certified Service Provider status for Parse Biosciences Evercode™ Whole Transcriptome technologies to expand access to scalable, high-quality single-cell analysis.
Admera Health Introduces a New Clinical-Grade Whole Genome Sequencing Solution to Its Suite of Genomic Services
Admera Health introduces a clinical-grade WGS service to its suite of genomics offerings to advance research with an added layer of confidence.
Admera Health Awards Grants to Seven Exceptional Researchers to Advance Their Single-Cell Studies
Admera Health announces the seven winners of their single-cell sequencing grant program powered by 10x Genomics technology.
Admera Health Expands its Reach with Strategic Acquisition of German-based BioEcho
Admera Health acquires BioEcho, boosting its NGS services with DNA/RNA extraction tech, expanding global presence and research capabilities.
Singleron Biotechnologies Appoints Admera Health as their Certified US Service Provider
Singleron Biotechnologies and Admera Health announced their strategic alliance at this year’s Festical of Genomics and Biodata in Boston, marking a significant step towards further empowering academic and pharmaceutical researchers across the United States.
STOmics to Welcome Admera Health into its Certified Service Provider Program
Admera Health, a leading provider of Next-Generation Sequencing services has partnered with STOmics, an advanced multi-omics company and developer of the spatial transcriptomics platform, Stereo-seq, to expand its Certified Service Provider (CSP) program.
Admera Health Announces its Acquisition of a NovaSeq X Plus
PRESS RELEASE
SOUTH PLAINFIELD, NEW JERSEY, USA, March 29, 2023 -- Admera Health, a leading provider of Next-Generation Sequencing services for researchers worldwide, has announced the acquisition of an Illumina NovaSeq X Plus sequencer to bolster its offering. The NovaSeq X Plus is a cutting-edge technology that enables high-throughput sequencing and supports a wide range of applications, including whole genome sequencing, transcriptome sequencing, targeted sequencing, single cell, and single-cell RNAseq.